Beneficial effect of butyrate-producing Lachnospiraceae on stress-induced visceral hypersensitivity in rats
- PMID: 30402954
- PMCID: PMC7379616
- DOI: 10.1111/jgh.14536
Beneficial effect of butyrate-producing Lachnospiraceae on stress-induced visceral hypersensitivity in rats
Abstract
Background and aim: Emerging evidence indicates that psychological stress is involved in the pathogenesis of irritable bowel syndrome, which is characterized by visceral hypersensitivity and may be accompanied by gut dysbiosis. However, how such stress contributes to the development of visceral hypersensitivity is incompletely understood. Here, we aimed to investigate the influence that stress-induced microbial changes exert on visceral sensitivity, as well as the possible underlying mechanisms associated with this effect.
Methods: Male Sprague-Dawley rats underwent chronic water avoidance stress (WAS) to induce visceral hypersensitivity. Visceral sensitivity, colonic tight junction protein expression, and short-chain fatty acids of cecal contents were measured. Fecal samples were collected to characterize microbiota profiles. In a separate study, oral gavage of Roseburia in WAS rats was conducted to verify its potential role in the effectiveness on visceral hypersensitivity.
Results: Repeated WAS caused visceral hypersensitivity, altered fecal microbiota composition and function, and decreased occludin expression in the colon. Stressed rats exhibited reduced representation of pathways involved in the metabolism of butyrate and reduced abundance of several operational taxonomic units associated with butyrate-producing bacteria, such as Lachnospiraceae. Consistently, supplementation with Roseburia hominis, a species belonging to Lachnospiraceae, significantly increased cecal butyrate content. Moreover, Roseburia supplementation alleviated visceral hypersensitivity and prevented the decreased expression of occludin.
Conclusions: Reduction in the abundance of butyrate-producing Lachnospiraceae, which is beneficial for the intestinal barrier, was involved in the formation of visceral hypersensitivity. R. hominis is a potential probiotic for treating stress-induced visceral hypersensitivity.
Keywords: butyrate; intestinal barrier; microbiota; stress; visceral hypersensitivity.
© 2018 The Authors. Journal of Gastroenterology and Hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Figures



































Similar articles
-
Multispecies probiotic protects gut barrier function in experimental models.World J Gastroenterol. 2014 Jun 14;20(22):6832-43. doi: 10.3748/wjg.v20.i22.6832. World J Gastroenterol. 2014. PMID: 24944474 Free PMC article.
-
Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.Gastroenterology. 2017 Oct;153(4):1026-1039. doi: 10.1053/j.gastro.2017.06.004. Epub 2017 Jun 15. Gastroenterology. 2017. PMID: 28624575
-
Paneth Cell Defects Induce Microbiota Dysbiosis in Mice and Promote Visceral Hypersensitivity.Gastroenterology. 2017 Dec;153(6):1594-1606.e2. doi: 10.1053/j.gastro.2017.08.044. Epub 2017 Sep 1. Gastroenterology. 2017. PMID: 28865734
-
Formation of propionate and butyrate by the human colonic microbiota.Environ Microbiol. 2017 Jan;19(1):29-41. doi: 10.1111/1462-2920.13589. Epub 2016 Dec 8. Environ Microbiol. 2017. PMID: 27928878 Review.
-
Early-life adversity, epigenetics, and visceral hypersensitivity.Neurogastroenterol Motil. 2017 Sep;29(9):10.1111/nmo.13170. doi: 10.1111/nmo.13170. Neurogastroenterol Motil. 2017. PMID: 28782197 Free PMC article. Review.
Cited by
-
Xylooligosaccharides Increase Bifidobacteria and Lachnospiraceae in Mice on a High-Fat Diet, with a Concomitant Increase in Short-Chain Fatty Acids, Especially Butyric Acid.J Agric Food Chem. 2021 Mar 31;69(12):3617-3625. doi: 10.1021/acs.jafc.0c06279. Epub 2021 Mar 16. J Agric Food Chem. 2021. PMID: 33724030 Free PMC article.
-
Maternal Selenium-Enriched Yeast Supplementation in Sows Enhances Offspring Growth and Antioxidant Status through the Nrf2/Keap1 Pathway.Antioxidants (Basel). 2023 Dec 1;12(12):2064. doi: 10.3390/antiox12122064. Antioxidants (Basel). 2023. PMID: 38136184 Free PMC article.
-
Lacticaseibacillus rhamnosus Strains for Alleviation of Irritable Bowel Disease and Chronic Fatigue Syndrome.Microorganisms. 2024 May 27;12(6):1081. doi: 10.3390/microorganisms12061081. Microorganisms. 2024. PMID: 38930463 Free PMC article.
-
Association of human gut microbiota composition and metabolic functions with Ficus hirta Vahl dietary supplementation.NPJ Sci Food. 2022 Sep 27;6(1):45. doi: 10.1038/s41538-022-00161-3. NPJ Sci Food. 2022. PMID: 36167833 Free PMC article.
-
Distinct Gut Microbiota Structure and Function of Children with Idiopathic Central and Peripheral Precocious Puberty.Int J Endocrinol. 2022 Nov 9;2022:7175250. doi: 10.1155/2022/7175250. eCollection 2022. Int J Endocrinol. 2022. PMID: 36405779 Free PMC article.
References
-
- Liu Y, Zhang L, Wang X et al Similar fecal microbiota signatures in patients with diarrhea‐predominant irritable bowel syndrome and patients with depression. Clin. Gastroenterol. Hepatol. 2016; 14: 1602–1611 e5. - PubMed
-
- Tap J, Derrien M, Tornblom H, Brazeilles R, Cools‐Portier S, Dore J, et al. Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology. 2016. - PubMed
-
- O'Mahony SM, Felice VD, Nally K et al Disturbance of the gut microbiota in early‐life selectively affects visceral pain in adulthood without impacting cognitive or anxiety‐related behaviors in male rats. Neuroscience 2014; 277: 885–901. - PubMed
-
- Sisson G, Ayis S, Sherwood RA, Bjarnason I. Randomised clinical trial: a liquid multi‐strain probiotic vs. placebo in the irritable bowel syndrome—a 12 week double‐blind study. Aliment Pharmacol. Ther. 2014; 40: 51–62. - PubMed
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical